Pharma Journalist - Page 798 of 923 -

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

UCB to Acquire Candid Therapeutics in $2.2 Billion Deal

Sanofi to acquire Ablynx for €3.9 Billion

BioCardia sought FDA approval for IDE for CMI Trial treating RA

CutisPharma confirms FDA’s sanction of FIRVANQ for Clostridium difficile

FDA reviews Theravance Biopharma and Mylan N.V NDA for Revefenacin

FDA extends 510(K) clearance for electroCore’s gammaCore (nVNS)

Emerald Health Information Systems changes to Harris Healthcare Clinical Solutions

Letco Medical and ARL Bio Pharma roll out Quality Savings Program